Lv622
2180 积分 2026-02-16 加入
Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
28天前
已完结
My Perspective on OBOC Combinatorial Technology
2个月前
已完结
Functional Peptides from One-bead One-compound High-throughput Screening Technique
2个月前
已完结
Efficacy and safety of tanezumab in the treatment of pain from bone metastases
2个月前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
2个月前
已完结
The coming of age of cyclic peptide drugs: an update on discovery technologies
2个月前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
5个月前
已完结
皖公网安备34019202002308
